🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Enbrel was first approved as new medicine on 06 Oct 2003 in Korea and the i...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01432249
Treatments Being Tested
This is a randomized, double-blind, parallel group, multicenter clinical st...
Status
Unknown
Location
Mochida Investigational site
Start Date
2015-02
Trial ID
NCT02357069
A potential application of therapeutic drug monitoring is to predict effica...
Status
Unknown
Location
Sint Maartenskliniek
Start Date
2020-07-31
Trial ID
NCT04251741
Treatments Being Tested
This study will provide data on additional therapeutic benefits in administ...
Status
Completed
Location
Winnipeg Clinic
Start Date
2007-03
Trial ID
NCT00927069
Treatments Being Tested
Demonstrate equivalent efficacy of GP2015 and EU-authorized Enbrel in patie...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-02-21
Trial ID
NCT02638259
Treatments Being Tested
This study will provide data on the addition of narrow band ultra violet B ...
Status
Completed
Location
Winnipeg Clinic
Start Date
2008-04
Trial ID
NCT00640393
Treatments Being Tested
This is a randomized, double-blind, parallel group, multicentre clinical st...
Status
Completed
Location
Investigational Site
Start Date
2013-06
Trial ID
NCT01895309
Treatments Being Tested
This observational study will be a documentation of the prescribing and adm...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT01188655
Treatments Being Tested
The Study objectives are: 1. To compare the efficacy and safety of Etanerc...
Status
Unknown
Location
PU Kryvyi Rih City Clinical Hospital №2 of the Dnipropetrovsk regional council
Start Date
2018-09-03
Trial ID
NCT04079374
Treatments Being Tested
To compare the efficacy of ETN 50mg twice weekly for 12 weeks followed by r...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-07
Trial ID
NCT00936065
Treatments Being Tested